GANX compared with NVA: revenue, margins and what each company keeps, and the suppliers and customers both name

GANXGain Therapeutics, Inc.

Mkt capRevenueRevenue

NVANova Minerals Corp

Mkt capRevenueRevenue

Compare

GANXGain Therapeutics, Inc.

NVANova Minerals Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

GANXGain Therapeutics, Inc.

1.14▼−4.30%· post 1.14

Mkt cap$49.3M

NVANova Minerals Corp

3.85▲+10.01%· post 3.98

ClosedOct 30 '26

Mkt cap$145.5M

Compare

ClosedOct 30 '26

GANXGain Therapeutics, Inc.

NVANova Minerals Corp

1.14▼−4.30%post 1.14

Price

3.85▲+10.01%post 3.98

$49.3M

Mkt cap

$145.5M

GANX1.14▼−4.30%vsNVA3.85▲+10.01%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

GANX, solidNVA, dashed

Supply-chain overlap

Revenue flow

GANX: latest quarter not drawable. NVA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GANX 1

—Minoryx Therapeutics, S.Lunlistedsupplier

Shared 0

No shared counterparties.

Only NVA 1

—Bureau Veritas Commodities Canadaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR